Adherence to Prescribing Indicators at a District Hospital in Ghana: Do We Match WHO Standards?
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Settings
General Setting
2.3. Specific Settings
2.3.1. Outpatient Department of the University Hospital, KNUST
2.3.2. Outpatient Medical Records
2.4. Study Population
2.5. Data Variables and Analysis
- Average number of medicines per encounter;
- Number and proportion of medicines prescribed by generic names;
- Number and proportion of encounters with an injection prescribed;
- Number and proportion of medicines prescribed from the Essential Medicines List.
3. Results
3.1. Medicines Prescribed per Patient Encounter
3.2. Medicines Prescribed in Generic Format
3.3. Prescriptions with Injections
3.4. Medicines Prescribed from the Essential Medicines List
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization The Rational Use of Drugs and WHO. Available online: https://apps.who.int/iris/bitstream/handle/10665/120708/em_rc33_r10_en.pdf (accessed on 5 August 2022).
- World Health Organization Promoting Rational Use of Medicines: Core Components. Available online: https://apps.who.int/iris/bitstream/handle/10665/67438/WHO_EDM_2002.3.pdf (accessed on 5 August 2022).
- Govindaraj, R.; Reich, M.R.; Cohen, J.C. World Bank Pharmaceuticals. License: CC BY 3.0 IGO. Available online: https://openknowledge.worldbank.org/handle/10986/13734 (accessed on 7 August 2022).
- Haque, M. Antimicrobial Use, Prescribing, and Resistance in Selected Ten Selected Developing Countries: A Brief Overview. Asian J. Pharm. Clin. Res. 2017, 10, 37–45. [Google Scholar] [CrossRef]
- O’Connor, M.N.; Gallagher, P.; Omahony, D. Inappropriate Prescribing: Criteria, Detection and Prevention. Drugs Aging 2012, 29, 437–452. [Google Scholar] [CrossRef] [PubMed]
- Davies, J. Where Have All the Antibiotics Gone? Can. J. Infect. Dis. Med. Microbiol. 2006, 17, 287–290. [Google Scholar] [CrossRef]
- Klein, E.Y.; Van Boeckel, T.P.; Martinez, E.M.; Pant, S.; Gandra, S.; Levin, S.A.; Goossens, H.; Laxminarayan, R. Global Increase and Geographic Convergence in Antibiotic Consumption between 2000 and 2015. Proc. Natl. Acad. Sci. USA 2018, 115, E3463–E3470. [Google Scholar] [CrossRef] [PubMed]
- Amponsah, O.K.O.; Buabeng, K.O.; Owusu-Ofori, A.; Ayisi-Boateng, N.K.; Hämeen-Anttila, K.; Enlund, H. Point Prevalence Survey of Antibiotic Consumption across Three Hospitals in Ghana. JAC-Antimicrobial Resist. 2021, 3, dlab008. [Google Scholar] [CrossRef] [PubMed]
- Versporten, A.; Zarb, P.; Caniaux, I.; Gros, M.F.; Drapier, N.; Miller, M.; Jarlier, V.; Nathwani, D.; Goossens, H.; Koraqi, A.; et al. Antimicrobial Consumption and Resistance in Adult Hospital Inpatients in 53 Countries: Results of an Internet-Based Global Point Prevalence Survey. Lancet Glob. Health 2018, 6, e619–e629. [Google Scholar] [CrossRef]
- Abeja, C.J.; Niyonzima, V.; Byagamy, J.P.; Obua, C. Antibiotic Prescription Rationality and Associated In-Patient Treatment Outcomes in Children under-Five with Severe Pneumonia at Bwizibwera Health Center IV, Mbarara District, South-Western Uganda. Pneumonia 2022, 14, 3. [Google Scholar] [CrossRef]
- World Health Organization Action Programme on Essential Drugs and Vaccines How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators. Available online: https://apps.who.int/iris/handle/10665/60519 (accessed on 2 November 2021).
- Ofori-Asenso, R. A Closer Look at the World Health Organization’s Prescribing Indicators. J. Pharmacol. Pharmacother. 2016, 7, 51–54. [Google Scholar] [CrossRef]
- Isah, A.; Laing, R.; Quick, J.; Mabadeje, A.F.B.; Santoso, B.; Hogerzeil, H.; Ross-Degnan, D. The Development of Reference Values for the WHO Health Facility Core Prescribing Indicators. West Afr. J. Pharmacol. Drug Res. 2001, 18, 6–11. [Google Scholar] [CrossRef]
- Amponsah, O.K.O.; Nagaraja, S.B.; Ayisi-Boateng, N.K.; Nair, D.; Muradyan, K.; Asense, P.S.; Wusu-Ansah, O.K.; Terry, R.F.; Khogali, M.; Buabeng, K.O. High Levels of Outpatient Antibiotic Prescription at a District Hospital in Ghana: Results of a Cross Sectional Study. Int. J. Environ. Res. Public Health 2022, 19, 10286. [Google Scholar] [CrossRef]
- 2021 Population and Housing Census—Ghana Statistical Service. Available online: https://census2021.statsghana.gov.gh/ (accessed on 3 November 2021).
- Ghana Hospitals Categories. Available online: https://www.ghanahospitals.org/categories/ (accessed on 3 November 2021).
- Ministry of Finance, G. Composite Budget for 2020–2023 Programme Based Budget Estimates for 2020 Oforikrom Municipal Assembly. Available online: https://www.mofep.gov.gh/sites/default/files/composite-budget/2020/AR/Oforikrom.pdf (accessed on 4 November 2021).
- Kluyver, T.; Ragan-Kelley, B.; Pérez, F.; Granger, B.; Bussonnier, M.; Frederic, J.; Kelley, K.; Hamrick, J.; Grout, J.; Corlay, S.; et al. Jupyter Notebooks-a Publishing Format for Reproducible Computational Workflows; IOS Press: Amsterdam, The Netherlands, 2016. [Google Scholar] [CrossRef]
- Shankar, P.R. Medicines Use in Primary Care in Developing and Transitional Countries: Fact Book Summarizing Results from Studies Reported between 1990 and 2006. Bull. World Health Organ. 2009, 87, 804. [Google Scholar] [CrossRef]
- Ofori-Asenso, R.; Brhlikova, P.; Pollock, A.M. Prescribing Indicators at Primary Health Care Centers within the WHO African Region: A Systematic Analysis (1995–2015). BMC Public Health 2016, 16, 724. [Google Scholar] [CrossRef] [PubMed]
- Irunde, H.; Minzi, O.; Moshiro, C. Assessment of Rational Medicines Prescribing in Healthcare Facilities in Four Regions of Tanzania. J. Pharm. Pract. Community Med. 2017, 3, 225–231. [Google Scholar] [CrossRef]
- Atif, M.; Sarwar, M.R.; Azeem, M.; Umer, D.; Rauf, A.; Rasool, A.; Ahsan, M.; Scahill, S. Assessment of WHO/INRUD Core Drug Use Indicators in Two Tertiary Care Hospitals of Bahawalpur, Punjab, Pakistan. J. Pharm. Policy Pract. 2016, 9, 27. [Google Scholar] [CrossRef]
- Cole, C.P.; Routledge, P. An Evaluation of Rational Prescribing in Hospital Outpatient Practice in Sierra Leone and Assessment of Affordability of a Prescription as an Outcome. Pan Afr. Med. J. 2018, 31, 174. [Google Scholar] [CrossRef]
- Baba, S.M.; Salifu, A.T. Medicines Prescribing Pattern in Northern Ghana: Does It Comply with WHO Recommendations for Prescribing Indicators? Afr. J. Pharm. Pharmacol. 2019, 13, 70–75. [Google Scholar] [CrossRef]
- Kapp, P.A.; Klop, A.C.; Jenkins, L.S. Drug Interactions in Primary Health Care in the George Subdistrict, South Africa: A Cross-Sectional Study. S. Afr. Fam. Pract. 2013, 55, 78–84. [Google Scholar] [CrossRef]
- Uzochukwu, B.S.C.; Onwujekwe, O.E.; Akpala, C.O. Effect of the Bamako-Initiative Drug Revolving Fund on Availability and Rational Use of Essential Drugs in Primary Health Care Facilities in South-East Nigeria. Health Policy Plan. 2002, 17, 378–383. [Google Scholar] [CrossRef]
- Tefera, B.B.; Getachew, M.; Kebede, B. Evaluation of Drug Prescription Pattern Using World Health Organization Prescribing Indicators in Public Health Facilities Found in Ethiopia: Systematic Reviews and Meta-Analysis. J. Pharm. Policy Pract. 2021, 14, 31. [Google Scholar] [CrossRef]
- King, D.R.; Kanavos, P. Encouraging the Use of Generic Medicines: Implications for Transition Economies. Croat. Med. J. 2002, 43, 462–469. [Google Scholar]
- Shrank, W.H.; Hoang, T.; Ettner, S.L.; Glassman, P.A.; Nair, K.; DeLapp, D.; Dirstine, J.; Avorn, J.; Asch, S.M. The Implications of Choice: Prescribing Generic or Preferred Pharmaceuticals Improves Medication Adherence for Chronic Conditions. Arch. Intern. Med. 2006, 166, 332–337. [Google Scholar] [CrossRef] [PubMed]
- Ministry of Health Ghana Medicine Prices in Ghana: A Comparative Study of Public, Private and Mission Sector Medicine Prices. Available online: https://haiweb.org/wp-content/uploads/2015/07/Ghana-Report-Pricing-Surveys.pdf (accessed on 16 September 2022).
- Cameron, A.; Laing, R. Cost Savings of Switching Private Sector Consumption from Originator Brand Medicines to Generic Equivalents. Available online: https://www.who.int/healthsystems/topics/financing/healthreport/35MedicineCostSavings.pdf (accessed on 27 August 2022).
- Godman, B.; Bishop, I.; Finlayson, A.E.; Campbell, S.; Kwon, H.Y.; Bennie, M. Reforms and Initiatives in Scotland in Recent Years to Encourage the Prescribing of Generic Drugs, Their Influence and Implications for Other Countries. Expert Rev. Pharm. Outcomes Res. 2013, 13, 469–482. [Google Scholar] [CrossRef] [PubMed]
- Ofori-Asenso, R.; Agyeman, A.A. A Review of Injection and Antibiotic Use at Primary Health Care (Public and Private) Centers in Africa. J. Pharm. Bioallied Sci. 2015, 7, 175–180. [Google Scholar] [CrossRef]
- Zhang, L.; Cao, S.; Marsh, N.; Ray-Barruel, G.; Flynn, J.; Larsen, E.; Rickard, C.M. Infection Risks Associated with Peripheral Vascular Catheters. J. Infect. Prev. 2016, 17, 207–213. [Google Scholar] [CrossRef] [PubMed]
- Sato, A.; Nakamura, I.; Fujita, H.; Tsukimori, A.; Kobayashi, T.; Fukushima, S.; Fujii, T.; Matsumoto, T. Peripheral Venous Catheter-Related Bloodstream Infection Is Associated with Severe Complications and Potential Death: A Retrospective Observational Study. BMC Infect. Dis. 2017, 17, 434. [Google Scholar] [CrossRef]
- Mermel, L.A. Short-Term Peripheral Venous Catheter–Related Bloodstream Infections: A Systematic Review. Clin. Infect. Dis. 2017, 65, 1757–1762. [Google Scholar] [CrossRef] [PubMed]
- Ghana National Drugs Programme Essential Medicines List. Available online: https://www.moh.gov.gh/wp-content/uploads/2020/07/GHANA-EML-2017.pdf (accessed on 27 August 2022).
- Aitken, M. Understanding the Role and Use of Essential Medicines Lists. Available online: https://www.ifpma.org/resource-centre/understanding-the-role-and-use-of-essential-medicines-lists/ (accessed on 27 August 2022).
- Atif, M.; Malik, I.; Dawoud, D.; Gilani, A.; Ahmed, N.; Babar, Z.U.D. Essential Medicine List, Policies, and the World Health Organization. In Encyclopedia of Pharmacy Practice and Clinical Pharmacy; Elsevier: Amsterdam, The Netherlands, 2019; pp. 239–249. ISBN 9780128127353. [Google Scholar]
- Von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gøtzsche, P.C.; Vandenbrouckef, J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Bull. World Health Organ. 2007, 85, 867–872. [Google Scholar] [CrossRef]
INDICATOR | NUMERATOR | DENOMINATOR | WHO OPTIMUM [12] |
---|---|---|---|
Average number of medicines per patient encounter | Total number of medicines prescribed | Total patient encounters for which data were collected | <2 |
Percentage of medicines prescribed by generic name | Total number of medicines prescribed in INN format | Total number of medicines prescribed | 100% |
Percentage of encounters with an injection prescribed | Number of encounters in which an injectable form of medicine was prescribed | Total patient encounters for which data were collected | <20% |
Percentage of medicines prescribed from an essential medicines list | Total number of medicines prescribed from the EML | Total number of medicines prescribed | 100% |
Month | Total Patient Encounters for Which Data were Collected | Total Number of Medicines Prescribed | Average Number of Medicines per Encounter | Lowest Number of Medicines Prescribed in an Encounter | Highest Number of Medicines Prescribed in an Encounter |
---|---|---|---|---|---|
January | 8488 | 23,652 | 2.8 | 1 | 12 |
February | 9406 | 29,794 | 3.2 | 1 | 13 |
March | 10,338 | 30,541 | 3 | 1 | 13 |
April | 8688 | 24,840 | 2.9 | 1 | 15 |
May | 8800 | 26,634 | 3 | 1 | 14 |
June | 11,679 | 35,538 | 3 | 1 | 15 |
July | 13,339 | 44,506 | 3.3 | 1 | 18 |
August | 10,640 | 31,262 | 2.9 | 1 | 15 |
September | 8343 | 24,740 | 3 | 1 | 16 |
October | 6864 | 21,144 | 3.1 | 1 | 13 |
November | 6421 | 19,115 | 3 | 1 | 15 |
December | 7274 | 24,321 | 3.3 | 1 | 14 |
Total | 110,280 | 336,087 | 3 | 1 | 18 |
Month | Total Number of Medicines Prescribed 1 | Total Number of Medicines Prescribed in INN Format | Proportion of Medicines Prescribed by Generic Names |
---|---|---|---|
January | 23,648 | 18,253 | 77% |
February | 29,789 | 23,022 | 77% |
March | 30,529 | 23,267 | 76% |
April | 24,832 | 18,674 | 75% |
May | 26,620 | 19,851 | 75% |
June | 35,516 | 26,195 | 74% |
July | 44,490 | 34,146 | 77% |
August | 31,251 | 23,831 | 76% |
September | 24,733 | 18,607 | 75% |
October | 21,137 | 15,909 | 75% |
November | 19,111 | 14,325 | 75% |
December | 24,312 | 17,907 | 74% |
Total | 335,968 | 253,987 | 76% |
Month | Total Patient Encounters for Which Data Were Collected | Total Number of Encounters with an Injection Prescribed | Proportion of Encounters with an Injection Prescribed |
---|---|---|---|
January | 8488 | 511 | 6% |
February | 9406 | 658 | 7% |
March | 10,338 | 658 | 6% |
April | 8688 | 588 | 7% |
May | 8800 | 569 | 6% |
June | 11,679 | 826 | 7% |
July | 13,339 | 927 | 7% |
August | 10,640 | 765 | 7% |
September | 8343 | 633 | 8% |
October | 6864 | 446 | 6% |
November | 6421 | 419 | 7% |
December | 7274 | 608 | 8% |
Total | 110,280 | 7608 | 7% |
Month | Total Number of Medicines Prescribed 1 | Total Number of Medicines Prescribed from EML | Proportion of Medicines Prescribed from EML |
---|---|---|---|
January | 23,648 | 21,461 | 91% |
February | 29,789 | 27,039 | 91% |
March | 30,529 | 27,491 | 90% |
April | 24,832 | 22,353 | 90% |
May | 26,620 | 23,623 | 89% |
June | 35,516 | 31,651 | 89% |
July | 44,490 | 39,830 | 90% |
August | 31,251 | 28,228 | 90% |
September | 24,733 | 22,401 | 91% |
October | 21,137 | 19,181 | 91% |
November | 19,111 | 17,089 | 89% |
December | 24,312 | 21,972 | 90% |
Total | 335,968 | 302,319 | 90% |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Amponsah, O.K.O.; Ayisi-Boateng, N.K.; Nagaraja, S.B.; Nair, D.; Muradyan, K.; Hedidor, G.K.; Labi, A.-K.; Opare-Addo, M.N.A.; Sarkodie, E.; Buabeng, K.O. Adherence to Prescribing Indicators at a District Hospital in Ghana: Do We Match WHO Standards? Int. J. Environ. Res. Public Health 2022, 19, 12260. https://doi.org/10.3390/ijerph191912260
Amponsah OKO, Ayisi-Boateng NK, Nagaraja SB, Nair D, Muradyan K, Hedidor GK, Labi A-K, Opare-Addo MNA, Sarkodie E, Buabeng KO. Adherence to Prescribing Indicators at a District Hospital in Ghana: Do We Match WHO Standards? International Journal of Environmental Research and Public Health. 2022; 19(19):12260. https://doi.org/10.3390/ijerph191912260
Chicago/Turabian StyleAmponsah, Obed Kwabena Offe, Nana Kwame Ayisi-Boateng, Sharath Burugina Nagaraja, Divya Nair, Karlos Muradyan, George Kwesi Hedidor, Appiah-Korang Labi, Mercy Naa Aduele Opare-Addo, Emmanuel Sarkodie, and Kwame Ohene Buabeng. 2022. "Adherence to Prescribing Indicators at a District Hospital in Ghana: Do We Match WHO Standards?" International Journal of Environmental Research and Public Health 19, no. 19: 12260. https://doi.org/10.3390/ijerph191912260